Feature Mati Therapeutics isn’t your traditional biotech startup By Len Zehr Not quite two years old yet, closely held Mati Therapeutics is conducting a pre-Phase 3 clinical trial with an ocular punctal plug delivery system (PPDS) that could become a preferred alternative to eye... June 10, 2014